Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry

Human coronaviruses (HCoVs) enter cells via two distinct pathways: the endosomal pathway using cathepsins to activate spike protein and the cell-surface or early endosome pathway using extracellular proteases such as transmembrane protease serine 2 (TMPRSS2). We previously reported that clinical iso...

Full description

Saved in:
Bibliographic Details
Published inVirology (New York, N.Y.) Vol. 517; pp. 9 - 15
Main Authors Shirato, Kazuya, Kawase, Miyuki, Matsuyama, Shutoku
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human coronaviruses (HCoVs) enter cells via two distinct pathways: the endosomal pathway using cathepsins to activate spike protein and the cell-surface or early endosome pathway using extracellular proteases such as transmembrane protease serine 2 (TMPRSS2). We previously reported that clinical isolates of HCoV-229E preferred cell-surface TMPRSS2 to endosomal cathepsin for cell entry, and that they acquired the ability to use cathepsin L by repeated passage in cultured cells and were then able to enter cells via the endosomal pathway. Here, we show that clinical isolates of HCoV-OC43 and -HKU1 preferred the cell-surface TMRRSS2 to endosomal cathepsins for cell entry, similar to HCoV-229E. In addition, the cell-culture-adapted HCoV-OC43 lost the ability to infect and replicate in air-liquid interface cultures of human bronchial tracheal epithelial cells. These results suggest that circulating HCoVs in the field generally use cell-surface TMPRSS2 for cell entry, not endosomal cathepsins, in human airway epithelial cells. •Clinical isolates of HCoV-OC43 and -HKU1 were isolated from ALI-cultured HBTE cells.•Clinical isolates of HCoVs preferred the TMRRSS2 to cathepsins for cell entry.•Cell culture adapted HCoV-OC43 lost the ability to replicate in HBTE-ALI culture.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0042-6822
1096-0341
1096-0341
DOI:10.1016/j.virol.2017.11.012